Trial Profile
AminoMedixTM for Radiation Kidney Protection During Peptide-Receptor Radionuclide Therapy (PRRT): Phase I, II Clinical Trial
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 29 Mar 2023
Price :
$35
*
At a glance
- Drugs Amifostine/amino acids (Primary)
- Indications Radiation sickness
- Focus Therapeutic Use
- 06 Nov 2016 New trial record